A clinical-statistical study on COVID-19 infection and death status at the Alshifaa Healthcare Center/ Baghdad
Open Access
- 1 October 2021
- journal article
- Published by Department of Chemistry and Biochemistry, Al-Nahrain University in Baghdad Journal of Biochemistry and Applied Biological Sciences
- Vol. 2 (04), 218-229
- https://doi.org/10.47419/bjbabs.v2i04.71
Abstract
Background: COVID-19 is an ongoing disease that caused, and still causes, many challenges for humanity. In fact, COVID-19 death cases reached more than 4.5 million by the end of August 2021, although an improvement in the medical treatments and pharmaceutical protocols was obtained, and many vaccines were released. Objective: To, statistically, analyze the data of COVID-19 patients at Alshifaa Healthcare Center (Baghdad, Iraq). Methods: In this work, a statistical analysis was conducted on data included the total number, positive cases, and negative cases of people tested for COVID-19 at the Alshifaa Healthcare Center/Baghdad for the period 1 September – 31 December 2020. The number of people who got the test was 1080, where 424 were infected and the rest of them were not. Results: The study showed that males’ infection and death cases were higher than females by more than double, despite the population ratios of the two genders being almost equal. Furthermore, as the age of patients is older, the chance of death is higher. Death cases were lower in December than the previous three months, which could be attributed to lower infection cases compared with the previous months. Conclusions: We can conclude that the peak of infected ages was the same as the other countries. Hence, the number of checked children was low, while we have the peak around the 40s and 50s. Females’ death cases were much less than males, which could be attributed to the genetic influence and the higher responsibility that females showed than males to prevent the disease’s spreading.Keywords
This publication has 24 references indexed in Scilit:
- Gender Differences in Patients With COVID-19: Focus on Severity and MortalityFrontiers in Public Health, 2020
- Therapeutic management of patients with COVID-19: a systematic reviewInfection Prevention in Practice, 2020
- Age-dependent effects in the transmission and control of COVID-19 epidemicsPublished by Cold Spring Harbor Laboratory ,2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in ChinaJournal of Autoimmunity, 2020
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart FailureCirculation Research, 2016
- Emerging markers in cardiovascular disease: Where does angiotensin‐converting enzyme 2 fit in?Clinical and Experimental Pharmacology and Physiology, 2013
- Combination renin–angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directionsClinical Science, 2012
- The dominance of human coronavirus OC43 and NL63 infections in infantsJournal of Clinical Virology, 2012
- Immunological Differences in Women Compared with Men: Overview and Contributing FactorsAmerican Journal of Reproductive Immunology, 2011